Loading…
The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease
Background Patients with primary sclerosing cholangitis associated with inflammatory bowel disease (PSC-IBD) have a very high risk of developing colorectal neoplasia. Alterations in the gut microbiota and/or gut bile acids could account for the increase in this risk. However, no studies have yet inv...
Saved in:
Published in: | United European gastroenterology journal 2018-02, Vol.6 (1), p.112-122 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Patients with primary sclerosing cholangitis associated with inflammatory bowel disease
(PSC-IBD) have a very high risk of developing colorectal neoplasia. Alterations in the
gut microbiota and/or gut bile acids could account for the increase in this risk.
However, no studies have yet investigated the net result of cholestasis and a
potentially altered bile acid pool interacting with a dysbiotic gut flora in the
inflamed colon of PSC-IBD.
Aim
The aim of this study was to compare the gut microbiota and stool bile acid profiles,
as well as and their correlation in patients with PSC-IBD and inflammatory bowel disease
alone.
Methods
Thirty patients with extensive colitis (15 with concomitant primary sclerosing
cholangitis) were prospectively recruited and fresh stool samples were collected. The
microbiota composition in stool was profiled using bacterial 16S rRNA sequencing. Stool
bile acids were assessed by high-performance liquid chromatography tandem mass
spectrometry.
Results
The total stool bile acid pool was significantly reduced in PSC-IBD. Although no major
differences were observed in the individual bile acid species in stool, their overall
combination allowed a good separation between PSC-IBD and inflammatory bowel disease.
Compared with inflammatory bowel disease alone, PSC-IBD patients demonstrated a
different gut microbiota composition with enrichment in Ruminococcus
and Fusobacterium genus compared with inflammatory bowel disease. At
the operational taxonomic unit level major shifts were observed within the
Firmicutes (73%) and Bacteroidetes phyla (17%).
Specific microbiota-bile acid correlations were observed in PSC-IBD, where 12% of the
operational taxonomic units strongly correlated with stool bile acids, compared with
only 0.4% in non-PSC-IBD.
Conclusions
Patients with PSC-IBD had distinct microbiota and microbiota-stool bile acid
correlations as compared with inflammatory bowel disease. Whether these changes are
associated with, or may predispose to, an increased risk of colorectal neoplasia needs
to be further clarified. |
---|---|
ISSN: | 2050-6406 2050-6414 |
DOI: | 10.1177/2050640617708953 |